Loading posts...
PSMA therapy with Lutetium-177 in treatment of metastatic prostate cancer
View

PSMA therapy with Lutetium-177 in treatment of metastatic prostate cancer

Prostate cancer is the second most common type of cancer in men. According to the world’s statistics, 1 of 9 men is diagnosed with this disease during the lifetime. It arises as a small localized tumor, but without proper treatment the neoplasm advances and a...